GRELOR (Ticagrelor) 60 mg/ 90 mg Tablet
As per the recent data available from the year 2017, CVDs contributed to 26.9% of total deaths and 12.8% of total DALYs (Disability-Adjusted Life Years) in Nepal. Ischemic heart disease was the predominant CVD, contributing 16.4% to total deaths and 7.5% to total DALYs.
With a mission to save lives, we introduce a better and preferred antiplatelet agent Ticagrelor as GRELOR. GRELOR is the Pioneer Nepalese Brand with quality, efficacy and reliability at reasonable and affordable price. GRELOR aims to reach out to the needy patients and save many lives
Go to this link to know more about this product.